Related Experiment Videos
[Effects of antiarrhythmic drugs on canine ventricular arrhythmia models]
1Department of Pharmacology, Yamanashi Medical College, Japan.
Abstract:
In order to compare and clarify the effects of various antiarrhythmic drugs, we examined drug effects on several canine arrhythmia models, simultaneously determining the minimum effective plasma concentrations. We used 1) two-stage coronary ligation arrhythmia, 2) digitalis arrhythmia, and 3) halothane-adrenaline arrhythmia. The following are, a summary of our results: Antiarrhythmic drugs of class 1 all suppressed digitalis arrhythmia, and except for lidocaine, also suppressed coronary ligation arrhythmia. Class 2 antiarrhythmic drugs, beta blockers, and class 4 antiarrhythmic drugs, Ca channel blockers, had common features of effectiveness, where they suppressed adrenaline arrhythmia in relatively low concentrations. Some differences among the antiarrhythmic effects of class 1 drugs could not be explained by their subclassification based either on action potential duration or kinetic properties of dissociation or association with Na channels. A new arrhythmia model for triggered activity in in vivo canine heart was developed, but drug effects on it does not seem to be very different from the effects on the other three arrhythmia models.
Insights
This study compared antiarrhythmic drug effectiveness in canine arrhythmia models, finding Class 1 drugs suppressed digitalis and coronary ligation arrhythmias. Beta and calcium channel blockers effectively treated adrenaline-induced arrhythmias.
Area of Science:
- Pharmacology
- Cardiovascular Science
- Translational Medicine
Context:
- Arrhythmias pose significant clinical challenges, necessitating effective antiarrhythmic drug therapies.
- Current antiarrhythmic drug classifications may not fully predict in vivo efficacy across diverse arrhythmia models.
- Canine models are crucial for preclinical evaluation of cardiovascular drug safety and efficacy.
Purpose:
- To compare the efficacy of various antiarrhythmic drug classes in established canine arrhythmia models.
- To determine the minimum effective plasma concentrations for different antiarrhythmic agents.
- To investigate the utility of a novel in vivo canine arrhythmia model for triggered activity.
Summary:
- Class 1 antiarrhythmic drugs effectively suppressed digitalis-induced arrhythmias and, with the exception of lidocaine, coronary ligation-induced arrhythmias.
- Class 2 (beta-blockers) and Class 4 (calcium channel blockers) demonstrated efficacy against halothane-adrenaline induced arrhythmias at relatively low concentrations.
- Subclassification of Class 1 drugs based on action potential duration or sodium channel kinetics did not fully explain observed antiarrhythmic effects. The novel triggered activity model showed similar drug responses.
Impact:
- Provides a comparative analysis of antiarrhythmic drug efficacy across multiple arrhythmia models.
- Highlights potential limitations in current antiarrhythmic drug classification systems.
- Offers insights into the development and application of novel arrhythmia models for drug screening.